Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae

Clinical Infectious Diseases

Volumn 40, Issue 9, 2005, Pages 1364-1367

  Hsu, Ron Bin ^a   Chen, Robert J ^a   Lin, Fang Yue ^a   Chu, Shu Hsun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CONTROLLED STUDY; EVALUATION; FEMALE; GASTROENTERITIS; HUMAN; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SALMONELLA; SALMONELLOSIS; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTROENTERITIS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SALMONELLA; SALMONELLA INFECTIONS;

EID: 17644379426     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/429325     Document Type: Article

References (25)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32:263-9.
2. Brown M, Eykyn SJ. Non-typhoidal Salmonella bacteraemia without gastroenteritis: a marker of underlying immunosuppression. Review of cases at St. Thomas' Hospital 1970-1999. J Infect 2000; 41:256-9.
3. Shimoni Z, Pitlik S, Leibovici L, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999; 28:822-7.
4. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis 1994; 19:777-80.
5. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of Salmonella infections. Medicine (Baltimore) 1987; 66:349-88.
6. Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 1999; 29:862-8.
7. Veraldi GF, de Manzoni G, Laterza E, et al. Extraintestinal infection by group C Salmonella: a case report and review of the literature. Hepatogastroenterology 2001; 48:471-4.
8. Hsu RB, Tsay YG, Wang SS, Chu SH. Management of aortic aneurysm infected with Salmonella. Br J Surg 2003; 90:1080-4.
9. Hsu RB, Tsay YG, Chen RJ, Chu SH. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003; 36:829-34.
10. Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis 2003; 16:467-72.
11. Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 2002; 26:141-8.
12. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994; 170:128-34.
13. Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002; 8:490-5.
14. NCCLS. Performance standard M2-A6. Wayne, PA: NCCLS, 1998.
15. Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with Salmonella bacteremia. Ann Intern Med 1978; 89:931-2.
16. Benenson S, Raveh D, Schlesinger Y, et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001; 110:60-3.
17. Fernandez Guerrero ML, Aguado JM, Arribas A, Lumbreras G, de Gorgolas M. The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 2004; 83:123-38.
18. Wang JH, Liu YC, Yen MY, et al. Mycotic aneurysm due to non-typhi Salmonella: report of 16 cases. Clin Infect Dis 1996; 23:743-7.
19. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 2002; 8:132-7.
20. Chiu CH, Lin TY, Ou JT. Prevalence of the virulence plasmids of nontyphoid Salmonella in the serovars isolated from humans and their association with bacteremia. Microbiol Immunol 1999; 43:899-903.
21. Chiu CH, Wu TL, Su LH, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002; 346:413-9.
22. Hsueh PR, Teng LJ, Tseng SP, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 2004; 10:60-8.
23. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39:546-51.
24. Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica Choleraesuis, Taiwan, 2000-2003. Emerg Infect Dis 2004; 10:1674-6.
25. Travers K, Barza M. Morbidity of infections caused by antimicrobial-resistant bacteria. Clin Infect Dis 2002; 34:S131-4.